{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T01:11:09Z","timestamp":1726276269517},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1992,4,1]],"date-time":"1992-04-01T00:00:00Z","timestamp":702086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>CD4+ (helper\/inducer) T lymphocyte subsets were studied in the peripheral blood from patients with mixed connective tissue disease (MCTD) by double-labelling immunofluorescence. The proportion of CD4+CD45RA+ cells was higher (P &amp;lt; 0\u00b701) when compared with controls, whereas CD4+CD29+ cells were markedly diminished (P &amp;lt; 0\u00b7001). CD4+CD29+ cells were lower than in patients with progressive systemic sclerosis who were studied in parallel. Upon stimulation with phytohaemagglutinin, CD4+ cells from MCTD patients showed a strong reactivity to acquire the CD29+ phenotype. Expression of high levels of CD29 and other adhesion molecules might lead to facilitated localization of CD4+ cells to inflamed tissue. It is suggested that an increased responsiveness of CD4+ cells to activation signals in vivo and accumulation of CD4+CD29+ cells at tissue sites could result in depletion of this cell subset in the peripheral blood of patients with MCTD.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1992.tb03044.x","type":"journal-article","created":{"date-parts":[[2010,7,27]],"date-time":"2010-07-27T10:33:48Z","timestamp":1280226828000},"page":"91-95","source":"Crossref","is-referenced-by-count":12,"title":["Imbalance of CD4+ lymphocyte subsets in patients with mixed connective tissue disease"],"prefix":"10.1093","volume":"88","author":[{"given":"H","family":"BECKER","sequence":"first","affiliation":[{"name":"III. Medizinische Klinik und Poliklinik, Universitat Giessen, Giessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"LANGROCK","sequence":"additional","affiliation":[{"name":"III. Medizinische Klinik und Poliklinik, Universitat Giessen, Giessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"FEDERLIN","sequence":"additional","affiliation":[{"name":"III. Medizinische Klinik und Poliklinik, Universitat Giessen, Giessen, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011703333730400_b1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/0002-9343(72)90064-2","article-title":"Mixed connective tissue disease: an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)","volume":"52","author":"Sharp","year":"1972","journal-title":"Am J Med"},{"key":"2022011703333730400_b2","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/00002281-199002060-00017","article-title":"Overlap syndromes and mixed connective tissue disease","volume":"2","author":"Maddison","year":"1990","journal-title":"Curr Opin Rheumatol"},{"key":"2022011703333730400_b3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00005792-198007000-00001","article-title":"Mixed connec tive tissue disease: a subsequent evaluation of the original 25 patients","volume":"159","author":"Nimelstein","year":"1980","journal-title":"Medicine"},{"key":"2022011703333730400_b4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/art.1780230312","article-title":"UndifTerentiated connective tissue syndromes","volume":"23","author":"LeRoy","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2022011703333730400_b5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00005792-198901000-00004","article-title":"Clinical and serologic characteristics of patients with overlap syndrome: is mixed connective tissue disease a distinct clinical entity","volume":"68","author":"Lazaro","year":"1989","journal-title":"Medicine"},{"key":"2022011703333730400_b6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/art.1780230308","article-title":"Suppressor cell loss and dysfunction in mixed connective tissue disease","volume":"23","author":"Alarcon-Segovia","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2022011703333730400_b7","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-1229(83)90086-7","article-title":"T-cell subpopulations in the peripheral blood of patients with connective tissue diseases as determined by flow cytometry using monoclonal antibodies","volume":"27","author":"Melendro","year":"1983","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703333730400_b8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0167-5699(91)90050-4","article-title":"The synergy between naive and memory T cells during activation","volume":"12","author":"Akbar","year":"1991","journal-title":"Immunol Today"},{"key":"2022011703333730400_b9","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1084\/jem.166.6.1758","article-title":"The subdivision of the T4 (CD4) subset on the basis of the differential expression of L-C\/T200 antigens","volume":"166","author":"Rudd","year":"1987","journal-title":"J Exp Med"},{"key":"2022011703333730400_b10","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4049\/jimmunol.134.3.1508","article-title":"The isolation and characterization of the human suppressor inducer T cell subset","volume":"134","author":"Morimoto","year":"1985","journal-title":"J Immunol"},{"key":"2022011703333730400_b11","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.4049\/jimmunol.140.7.2171","article-title":"Loss of CD45R and gain of UCHLI reactivity is a feature of primed T cells","volume":"140","author":"Akbar","year":"1988","journal-title":"J Immunol"},{"key":"2022011703333730400_b12","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.4049\/jimmunol.134.6.3762","article-title":"The isolation and characterization of the human helper inducer T cell subset","volume":"134","author":"Morimoto","year":"1985","journal-title":"J Immunol"},{"key":"2022011703333730400_b13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.140.5.1401","article-title":"Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHLI, CDw29, and Pgp-I) and have enhanced IFN-I production","volume":"140","author":"Sanders","year":"1988","journal-title":"J Immunol"},{"key":"2022011703333730400_b14","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.4049\/jimmunol.141.10.3249","article-title":"Differential activation require ments for virgin and memory T cells","volume":"141","author":"Byrne","year":"1988","journal-title":"J Immunol"},{"key":"2022011703333730400_b15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0090-1229(90)90147-I","article-title":"Soluble and cellular markers of immune activation in patients with systemic sclerosis","volume":"56","author":"Degiannis","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703333730400_b16","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1002\/art.1780300802","article-title":"Deficiency of the suppressor inducer subset of T lymphocytes in rheumatoid arthritis","volume":"30","author":"Emery","year":"1987","journal-title":"Arthritis Rheum"},{"key":"2022011703333730400_b17","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/ard.49.1.40","article-title":"Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis","volume":"47","author":"Gustafsson","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"2022011703333730400_b18","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1172\/JCI112882","article-title":"A defect of immunoregulatory T cell subsets in systemic lupus erythematosus patients demonstrated with anti-2H4 antibody","volume":"79","author":"Morimoto","year":"1987","journal-title":"J Clin Invest"},{"key":"2022011703333730400_b19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma)","volume":"23","author":"Masi","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2022011703333730400_b20","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0090-1229(90)90143-E","article-title":"Relationship between CD5+ B lymphocytes and the activity of systemic autoimmunity","volume":"56","author":"Becker","year":"1990","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703333730400_b21","first-page":"365","article-title":"B lymphocyte activation by insoluble anti-\u03bc antibodies in patients with systemic lupus erythema tosus","volume":"66","author":"Becker","year":"1986","journal-title":"Clin Exp Immunol"},{"key":"2022011703333730400_b22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-1759(82)90353-2","article-title":"Alternative fluorochromes to ethidium bromide for automated read out of cytotoxicity tests","volume":"52","author":"Tanke","year":"1982","journal-title":"J Immunol Methods"},{"key":"2022011703333730400_b23","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/j.1365-2249.1990.tb05340.x","article-title":"Soluble interleukin-2 receptor, interleukin-2 and interleukin-4 in sera and supematants from patients with progressive systemic sclerosis","volume":"81","author":"Famularo","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"2022011703333730400_b24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/art.1780310312","article-title":"Enhanced production of interleukin-2 in patients with progres sive systemic sclerosis","volume":"31","author":"Umehara","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2022011703333730400_b25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.7326\/0003-4819-110-6-446","article-title":"Interleukin-2 in scleroderma: correlation of serum level with extent of skin involvement and disease duration","volume":"110","author":"Kahaleh","year":"1989","journal-title":"Ann Intern Med"},{"key":"2022011703333730400_b26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0090-1229(84)90195-8","article-title":"Interleukin 2 deficiencies in rheumatoid arthritis and systemic lupus erythematosus","volume":"31","author":"Miyasaka","year":"1984","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703333730400_b27","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1365-2249.1991.tb05682.x","article-title":"Detection of circulating FceR2\/CD23+ monocytes in patients with rheumatic diseases","volume":"85","author":"Becker","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"2022011703333730400_b28","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/eji.1830190908","article-title":"Lymphokine gene expression related to CD4 T cell subset (CD45R\/CDw29) phenotype conversion","volume":"19","author":"Bettens","year":"1989","journal-title":"Eur J Immunol"},{"key":"2022011703333730400_b29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0090-1229(88)90022-0","article-title":"Age-related changes in human lymphocyte subsets: progressive reduction of the CD4CD45R (suppressor inducer) population","volume":"48","author":"De Paoli","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703333730400_b30","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.140.5.1435","article-title":"Loss of CD45R (Lp220) represents a post-thymic T cell differentiation event","volume":"140","author":"Serra","year":"1988","journal-title":"J Immunol"},{"key":"2022011703333730400_b31","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1365-3083.1990.tb02917.x","article-title":"Phenotypical and functional differentiation of CD4+CD45RA+ human T cells following polyclonal activation","volume":"32","author":"Kristensson","year":"1990","journal-title":"Scand J Immunol"},{"key":"2022011703333730400_b32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0167-5699(91)90051-T","article-title":"T-cell memory: the connection between function, phenotype and migration pathways","volume":"12","author":"Mackay","year":"1991","journal-title":"Immunol Today"},{"key":"2022011703333730400_b33","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0090-1229(87)90040-7","article-title":"Abnormal distribution of the helper-inducer and suppressor-inducer T-lymphocyte subsets in the rheumatoid joint","volume":"45","author":"Pitzalis","year":"1987","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011703333730400_b34","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/eji.1830210218","article-title":"Selective migration of the human helper-inducer memory T cell subset: confirmation by in vivo cellular kinetic studies","volume":"21","author":"Pitzalis","year":"1991","journal-title":"Eur J Immunol"},{"key":"2022011703333730400_b35","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.4049\/jimmunol.144.4.1233","article-title":"Ability of human T lymphocytes to adhere to vascular endothelial cells and to augment endothelial permeability to macromolecules is linked to their state of post-thymic maturation","volume":"144","author":"Damle","year":"1990","journal-title":"J Immunol"},{"key":"2022011703333730400_b36","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.1780270607","article-title":"Lympho cytes in the skin of patients with progressive systemic sclerosis","volume":"27","author":"Roumm","year":"1984","journal-title":"Arthritis Rheum"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1992.tb03044.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/88\/1\/91\/42212757\/j.1365-2249.1992.tb03044.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/88\/1\/91\/42212757\/j.1365-2249.1992.tb03044.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T10:40:14Z","timestamp":1685702414000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/88\/1\/91\/6488199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,4]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1992.tb03044.x","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[1992,4]]},"published":{"date-parts":[[1992,4]]}}}